Q4 2021
Released Feb 23, 2022, after the close
10-K filed Feb 24, 2022, 55 days after period end · 0001653477-22-000008
Q4 2021 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$336.00M$336.00M derived+3.2% vs Q4 2020−10.8% vs Q3 2021
Net Income$29.30M$29.30M derived−36.3% vs Q4 2020N/M vs Q3 2021
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$105,000,000−17.6%
Operating Incomederived$79,600,000−28.2%
Operating Cash Flowderived$76,300,000−50.2%
Free Cash Flowderived$38,900,000−68.2%
Margins · derived
Gross margin31.3%−7.9 pt vs Q4 2020
Operating margin23.7%−10.4 pt vs Q4 2020
Net margin8.7%−5.4 pt vs Q4 2020
What the release said
The release
Same quarter
| Metric | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|
| Revenue | $336.00M | $325.60M | $303.40M | $278.60M |
| Net Income | $29.30M | $46.00M | $44.30M | $42.10M |
| EPS Diluted | — | $1.11 | $1.05 | $0.99 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR